Rapid production of novel pre-microRNA agent hsa-mir-27b in Escherichia coli using recombinant RNA technology for functional studies in mammalian cells.
about
Bioengineering of noncoding RNAs for research agents and therapeuticsA general approach to high-yield biosynthesis of chimeric RNAs bearing various types of functional small RNAs for broad applications.Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity.Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional CharacterizationMicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective TherapymiRNA-27b levels are associated with CYP3A activity in vitro and in vivo.Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest.Bioengineered non-coding RNA agent (BERA) in action.Recombinant pre-miR-29b for Alzheimer´s disease therapeutics.Upregulated effects of miR-7 in methicillin-resistant Staphylococcus aureusBioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells.Advances in time course extracellular production of human pre-miR-29b from Rhodovulum sulfidophilum.Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy.
P2860
Q26772092-8FF3E3B8-4CE3-4B70-9F27-9E8F1A045140Q35476690-8705277A-56F1-4B7C-A544-A7042BD11BEFQ35745244-5AA9DB4D-4448-4F13-84E9-8C3FDD4A8F87Q35897815-86BF2543-AF6F-4C19-BAF3-4E3E531324E8Q36618667-16C351BA-7FED-4F5C-85CA-1D56AD737F07Q36648836-C053A8D2-613D-45B2-9DF7-8AA38E1B9708Q36928436-44BDF43E-5066-4AF2-97BE-EB760A460C25Q37391959-FDB30FBF-7C86-4056-A624-188A2E501728Q38799079-4230702E-952E-47E8-880A-3E9AF4492C34Q41372468-5D04C3E8-629A-4B38-8513-80912B8018D1Q46256395-3E01EB1F-E7D7-4A0A-8435-ED332832F583Q48243256-6D651397-B242-4F00-BC94-F07ED9F83EE5Q52618071-5F1A07E9-D317-41C3-A2B8-E28D483F2DDE
P2860
Rapid production of novel pre-microRNA agent hsa-mir-27b in Escherichia coli using recombinant RNA technology for functional studies in mammalian cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Rapid production of novel pre- ...... al studies in mammalian cells.
@ast
Rapid production of novel pre- ...... al studies in mammalian cells.
@en
Rapid production of novel pre- ...... al studies in mammalian cells.
@nl
type
label
Rapid production of novel pre- ...... al studies in mammalian cells.
@ast
Rapid production of novel pre- ...... al studies in mammalian cells.
@en
Rapid production of novel pre- ...... al studies in mammalian cells.
@nl
prefLabel
Rapid production of novel pre- ...... al studies in mammalian cells.
@ast
Rapid production of novel pre- ...... al studies in mammalian cells.
@en
Rapid production of novel pre- ...... al studies in mammalian cells.
@nl
P2093
P2860
P356
P1476
Rapid production of novel pre- ...... al studies in mammalian cells.
@en
P2093
Ai-Ming Yu
Mei-Mei Li
Wei-Peng Wang
Wen-Juan Wu
P2860
P304
P356
10.1124/DMD.114.060145
P577
2014-08-26T00:00:00Z